Research project

An open, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (PolaRICE) with rituximab, ifosfamide, carboplatin and etoposide (RICE)

Research groups:
Lead researcher:

Professor Andy Davies
Other researchers:

Professor Gareth Griffiths
Status:

Active

Staff

Lead researcher

Professor Andy Davies BSc (Hons) BM (Hons) PhD FRCP

Professor of Haematological Oncology

Connect with Andy

Email: [email protected]

Other researchers

Professor Gareth Griffiths

Director Clinical Trials Unit

Connect with Gareth

Email: [email protected]

Collaborating research institutes, centres and groups

Southampton Clinical Trials Unit (SCTU)

We deliver world-leading clinical trials of innovative new treatments and diagnostic tools. Our trials directly influence routine clinical practice for the benefit of patients.